Effectiveness of posttransplant prophylaxis with anti-hepatitis B virus immunoglobulin in recipients of heart transplant from hepatitis B virus core antibody positive donors

被引:6
作者
Krassilnikova, Maria
Deschenes, Marc
Tchevenkov, Jean
Giannetti, Nadia
Cecere, Renzo
Cantarovich, Marcelo
机构
[1] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Multi Organ Transplant Program,Dept Med, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Cardiovasc & Thorac Surg, Montreal, PQ H3A 1A1, Canada
[3] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, Canada
[4] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Surg, Montreal, PQ H2W 1S4, Canada
关键词
D O I
10.1097/01.tp.0000264551.41668.4e
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1523 / 1524
页数:2
相关论文
共 9 条
[1]   Risk of transmission of hepatitis B virus from anti-HBc positive cadaveric organ donors: A collaborative study [J].
De Feo, TM ;
Poli, F ;
Mozzi, F ;
Moretti, MP ;
Scalamogna, M .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :1238-1239
[2]   Hepatitis B vaccination in heart transplant candidates [J].
Foster, WQ ;
Murphy, A ;
Vega, DJ ;
Smith, AL ;
Hott, BJ ;
Book, WM .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (01) :106-109
[3]   Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine [J].
Nery, JR ;
Nery-Avila, C ;
Reddy, KR ;
Cirocco, R ;
Weppler, D ;
Levi, DM ;
Nishida, S ;
Madariaga, J ;
Kato, T ;
Ruiz, P ;
Schiff, E ;
Tzakis, AG .
TRANSPLANTATION, 2003, 75 (08) :1179-1186
[4]   Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies [J].
Pinney, SP ;
Cheema, FH ;
Hammond, K ;
Chen, JM ;
Edwards, NM ;
Mancini, D .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (01) :34-37
[5]   Prevention of hepatitis B recurrence after liver transplantation [J].
Seehofer, D ;
Berg, T .
TRANSPLANTATION, 2005, 80 (01) :S120-S124
[6]   Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants [J].
Uemoto, S ;
Sugiyama, K ;
Marusawa, H ;
Inomata, Y ;
Asonuma, K ;
Egawa, H ;
Kiuchi, T ;
Miyake, Y ;
Tanaka, K ;
Chiba, T .
TRANSPLANTATION, 1998, 65 (04) :494-499
[7]  
WAGNER D, 1994, CLIN INVESTIGATOR, V72, P350
[8]   Long-term outcome of chronic hepatitis B in heart transplant recipients [J].
Wedemeyer, H ;
Pethig, K ;
Wagner, D ;
Flemming, P ;
Oppelt, P ;
Petzold, DR ;
Haverich, A ;
Manns, MP ;
Boeker, KHW .
TRANSPLANTATION, 1998, 66 (10) :1347-1353
[9]   Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis [J].
Zheng, SS ;
Chen, YM ;
Liang, TB ;
Lu, AW ;
Wang, WL ;
Shen, Y ;
Zhang, M .
LIVER TRANSPLANTATION, 2006, 12 (02) :253-258